semaglutide vs tirzepatide side effects vs. for Weight Loss Semaglutide vs Tirzepatide: Differences, Cost,

Back to Journals Vascular Health and Risk Management Volume 12 SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives Authors Gurgle H, White K, McAdam-Marx C Received 14 November 2015 Accepted for publication 11 March 2016 Published 4 June 2016 Volume 2016:12 Pages 239249 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 5 Editor who approved publication: Dr Daniel Duprez Holly E Gurgle, Karen White, Carrie McAdam-Marx Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA Abstract: Controversy exists regarding the selection of second-line therapy for patients with type 2 diabetes mellitus (T2DM) who are unable to achieve glycemic control with metformin therapy alone

Long-term trials confirm it can still deliver meaningful and sustainable benefits for many patients

Weighing in on the big success has many of the experts thrilled

The only legal way to access it is through an authorized clinical trial

I was still snacking between meals, and the promise of fullness never happened

I don't doubt that